• Skip to main content
  • Skip to footer

Life Sciences British Columbia

  • Members Area |
  • Contact Us
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
    • LSBC Hall of Fame
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login
Search
Generic filters

AbbVie Corporation

Member Profile

A company that takes on the toughest health challenges. AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.ca and www.abbvie.com. Follow @abbviecanada on Twitter or find us on Facebook, LinkedIn and Instagram

Sector
Global Pharmaceutical Corporations, Therapeutics
Area of Expertise
  • Autoimmune Diseases
  • Drug Discovery
  • Inflammatory Diseases
  • Mental & Behavioral Health
  • Neurological Diseases
  • Oncology
  • Ophthalmology
  • Women’s Health
Company Stage Public Company
Employees outside Canada 46,000 employees
Stock Ticker ABBV - NYSE

Member Profile

Global Pharmaceutical Corporations, Therapeutics

AbbVie Corporation

Bronze Sponsor

  • Website www.abbvie.ca
  • Phone +1 (888) 703 3006
  • Email communications-canada@abbvie.com
  • Address
    8401 Trans-Canada Highway
    Saint-Laurent, QC
    H4S 1Z1
  • Leadership Contact
    Richard A. Gonzalez, Chairman of the Board & CEO
    Follow us:
  • Twitter
  • Facebook
  • LinkedIn
  • Instagram
  • News
  • Jobs

July 20, 2022

AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma

July 18, 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

June 27, 2022

CHMP Recommends Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis

June 21, 2022

AbbVie Submits Supplemental New Drug Application to U.S. FDA for Atogepant (QULIPTA™) to Support Label Expansion for the Preventive Treatment of Migraine

May 11, 2022

Upadacitinib (RINVOQ®) Achieved Clinical Remission and Endoscopic Response at One Year in Phase 3 Maintenance Study in Patients with Crohn’s Disease

No current content.

  • Twitter
  • Linkedin
Tweets by AbbVie Corporation
Connect with us LinkedIn

© 2022 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us